Evidence map›Paper›PMID 28555330›Full record

ArticlePurinergic signalling2017

The P2Y

Tassya Cataldi Cardoso, Thaís Emanuelle Pompeu, Claudia Lucia Martins Silva

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Purinergic signalling, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Quantifying Adhesion of Inflammatory Cells to the Endothelium In Vitro.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tassya Cataldi CardosoLaboratory of Biochemical and Molecular Pharmacology, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Av. Carlos Chagas Filho, 373 CCS room J-17, Cidade Universitária CEP 21941-599, Rio de Janeiro, RJ, 21941-902, Brazil.
Thaís Emanuelle PompeuLaboratory of Biochemical and Molecular Pharmacology, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Av. Carlos Chagas Filho, 373 CCS room J-17, Cidade Universitária CEP 21941-599, Rio de Janeiro, RJ, 21941-902, Brazil.
Claudia Lucia Martins SilvaLaboratory of Biochemical and Molecular Pharmacology, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Av. Carlos Chagas Filho, 373 CCS room J-17, Cidade Universitária CEP 21941-599, Rio de Janeiro, RJ, 21941-902, Brazil. cmartins@icb.ufrj.br.
Universidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular ATP (released by endothelial and immune cells) and its metabolite ADP are important pro-inflammatory mediators via the activation of purinergic P2 receptors (P2Y and P2X), which represent potential new targets for anti-inflammatory therapy. Endothelial P2Y

Indexed as

Adenosine DiphosphateAnimalsCalciumCell AdhesionEndothelial CellsLeukocytes, MononuclearMaleMelatoninRats, WistarReceptors, Leukocyte-AdhesionReceptors, Purinergic P2Y1Signal TransductionAdenosine DiphosphateCalciumMelatoninReceptors, Leukocyte-AdhesionReceptors, Purinergic P2Y1Endothelial cellsInflammationMelatoninP2Y1 receptorPurinergic signaling

Identifiers

PMID28555330
PMCPMC5563294
OpenAlexW2618573394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.